What is Drug Trends? funded by the Australian Government under the Substance Misuse Prevention and Service Improvement Grants Fund

Similar documents
Key findings from the 2014 Illicit Drug Reporting System

2014 Key Australian findings: psychostimulant drug market

Key findings for drug use patterns & drug markets

Key findings from the 2014 IDRS: a survey of people who inject drugs

trends bulletin ecstasy and related drug Key findings An overview of the 2011 EDRS: What is happening to ecstacy and related drugs in Australia?

illicit drug reporting system drug trends bulletin Key findings from the 2015 IDRS: a survey of people who inject drugs Introduction

Drug related hospital stays in Australia

Drug-related hospital stays in Australia

An overview of the 2014 Ecstasy and Related Drugs. Reporting System. Ecstasy and Related Drugs. drug trends bulletin October 2014

EMBARGOED NOT FOR RELEASE PRIOR TO AM WEDNESDAY OCTOBER

Developing a drug monitoring system for New Zealand: IDMS

An overview of the 2015 Ecstasy and Related Drugs. Reporting System. Ecstasy and Related Drugs. drug trends bulletin October 2015

AUSTRALIAN. Capital Territory. Kerryn Butler & Courtney Breen ACT DRUG TRENDS Findings from the. Illicit Drug Reporting System (IDRS)

Ecstasy and Related Drugs Reporting System: 2016 Findings

Drug-related hospital stays in Australia

Ecstasy and Related Drugs Reporting System drug trends bulletin April 2014

AUSTRALIAN. Capital Territory

Methamphetamine Use in Australia: What the data tells us about patterns of use & users. methamphetamine

Ecstasy and Related Drugs Reporting System drug trends bulletin April 2013 Supplement

Fairlie McIlwraith and Rosa Alati. QUEENSLAND DRUG TRENDS 2014 Findings from the Illicit Drug Reporting System (IDRS)

S. O Brien, E. Black, L. Degenhardt, A. Roxburgh, G. Campbell, B. de Graaff, J. Fetherston, R. Jenkinson, S. Kinner, C. Moon and N.

Victorian Drug Trends 1998

J. Fetherston and S. Lenton WA DRUG TRENDS 2017 Findings from the Illicit Drug Reporting System (IDRS) Australian Drug Trends Series No.

Overview of the Australian National Drug Strategy Household Survey (NDSHS)

Author: Laura A Scott and Lucy Burns, National Drug and Alcohol Research Centre, University of New South Wales

Australian Drug Trends Key findings from the National Illicit Drug Reporting System (IDRS) Interviews

NEW SOUTH WALES DRUG TRENDS 2018: KEY FINDINGS FROM THE ECSTASY AND RELATED DRUGS REPORTING SYSTEM (EDRS) INTERVIEWS

J. Fetherston and S. Lenton WA DRUG TRENDS 2012 Findings from the Illicit Drug Reporting System (IDRS) NDARC Technical Report No.

Arthur Truong, Paul Dietze & Belinda Lloyd

Illicit Opioid and Methamphetamine Trends in Maine

Annual Reports Questionnaire (ARQ) Part III: Extent, patterns and trends in drug use

Ecstasy and Related Drugs Reporting System drug trends bulletin July 2012

ILLICIT DRUG REPORTING SYSTEM DRUG TRENDS BULLETIN

Understanding how a high-level drug trafficking network in Australia adapts to changes in its drug supply

Part of the Continuum of Care. Harm Reduction. Gino Vumbaca President Harm Reduction Australia

KEY FINDINGS FROM THE NATIONAL ECSTASY AND RELATED DRUGS REPORTING SYSTEM (EDRS) INTERVIEWS

OVERDOSE DEATHS IN AUSTRALIA COCAINE AND METHAMPHETAMINE MENTIONS IN ACCIDENTAL DRUG-INDUCED DEATHS IN AUSTRALIA,

BENZODIAZEPINE DEPENDENCE AMONG MULTIDRUG USERS IN THE CLUB SCENE. Steven P. Kurtz and Mance E. Buttram

World Drug Report 2017

A Snapshot of Substance Use: Licit and Illicit Drug Use Yesterday among People Who Inject Drugs in Australia ( ).

NORTHERN TERRITORY DRUG TRENDS 2018: KEY FINDINGS FROM THE ECSTASY AND RELATED DRUGS REPORTING SYSTEM (EDRS) INTERVIEWS

Drug Surveillance Systems in Canada

Measuring the Illegal Drug Economy of Australia in a National Accounts Framework: Some Experimental Estimates Drug Policy Modelling Program Symposium

Anyone Can Become Addicted. Anyone.

Western Australia. J. Fetherston and S. Lenton. WA DRUG TRENDS 2013 Findings from the Illicit Drug Reporting System (IDRS)

Taking Stock of the 2009 PoA Research and Trend Analysis Branch

and practice: Three AIC examples Dr Adam Tomison

Rise in LSD use among Regular Psychostimulant Users: Why the increase and is it a cause for concern?

Northern Territory Drug Trends 1999

Annual report 2012: the state of the drugs problem in Europe

Models of good practice in drug treatment in Europe. Project group

2002 AUSTRALIAN BUREAU OF STATISTICS DATA ON ACCIDENTAL DRUG-INDUCED DEATHS DUE TO OPIOIDS

A reduction in the availability of heroin in Australia

Challenging the notion of an ice epidemic in Victoria with drug trend monitoring data

Cocaine and Methamphetamine related drug-induced deaths in Australia, 2011

RECENT TRENDS IN ILLEGAL DRUG USE IN NEW ZEALAND,

Emma Black and Louisa Degenhardt National Drug and Alcohol Research Centre University of New South Wales

9. In comparing the relative toxicity of marijuana and cocaine, it is important to take into account A. the user's gender. B. availability and price.

The role of UNODC in working law enforcement agencies to promote harm reduction. IHRC, Bangkok, 23 April 2009

Global drug trends and sustainable development

trends bulletin ecstasy and related drug Key findings

What is harm reduction?

Ecstasy and Related Drugs Reporting System drug trends bulletin

HIV/AIDS Think Tank meeting: EMCDDA report. Roland Simon, Klaudia Palczak, EMCDDA Luxembourg, 7 July 2015

Changes in the NPS market in Eastern and Central Europe

EDRS. trends. bulletin. Alcohol use disorders amongst a group of regular ecstasy users. Key findings. july Introduction.

Statistics on Drug Misuse: England, 2008

N.Sindicich, J.Stafford & C.Breen

PH52. Audit tool for the implementation of. NICE public health guidance 52 Needle and syringe programmes

REDUCING ALCOHOL AND OTHER DRUG IMPACTS IN QUEENSLAND

Review of illicit drug use among Aboriginal and Torres Strait Islander people

Controlled Substances

drug trends bulletin Driving behaviours among people who inject drugs in South Australia, Key findings december 2011 ISSN

Claire Gilbert, Tony Margetts, Gilda Nunez, Bryony Sedgwick, Tim Allison. Thanks to Hull Public Health, Prof. Marks and Paul Smith

JSNA Substance Misuse

Presenters. Session Objectives. Session Overview. Cluster Investigations in Rural Wisconsin

End the Epidemic. Miami-Dade County COMPREHENSIVE COMMUNITY PREVENTION ACTION PLAN

Patterns of mephedrone, GHB, Ketamine and Rohypnol use among police detainees: Findings from the DUMA program

Drug Trend Bulletin - Issue 19 March 2019.

Substance use and misuse

S. Cogger, P. Dietze & B. Lloyd. VICTORIAN DRUG TRENDS 2012 Findings from the Illicit Drug Reporting System (IDRS)

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

Other Models of Addictions Treatment

Patient Care Planning Group April 3, 2014

Statistics on Drug Misuse: England, 2009

Fatalities and other key cocaine/crack cocaine indicators for the United Kingdom,

Frequently Asked Questions about Supervised Injecting Facilities 24 July 2014

Cocaine. Key Points 60 ILLICIT DRUG DATA REPORT

Cocaine Use Among a Sample of Police Detainees

Acute Drug Toxicity Data

Young people and AOD Strategies and support. Eden Wheatley (Program Coordinator)

How can we/should we study purported changes in drug market supply?

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

Professor Paul I Dargan

Methamphetamines, Mental Health and Drug Law Reform

Methadone Diversion: Why it happens, what the illicit market looks like and the implications

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

PERFORMANCE AND IMAGE ENHANCING DRUGS

CHARACTERISTICS OF AMPHETAMINE-TYPE STIMULANT (ATS) USE IN NEW ZEALAND: INFORMING POLICY RESPONSES

Transcription:

What is Drug Trends? funded by the Australian Government under the Substance Misuse Prevention and Service Improvement Grants Fund

Outline How do we monitor drug trends in Australia Aims Methodology Drug user interviews Key expert interviews Indicator data Findings from the IDRS/EDRS Summary

How do we monitor drug trends in Australia? Population surveys Targeted sample surveys Gay periodic Survey Secondary indicator data sources e.g. Causes of death database, Emergency Department presentations, criminal statistics Internet Monitoring Other technologies e.g. Biological samples (wastewater, blood)

Beginnings 1990 s Government identified challenges to monitoring trends in the illicit drug market 1990-1991: Criminologist Dr Grant Wardlaw running an Illicit Drug Indicators project-too slow and cumbersome Dr Grant Wardlaw ANU College of Asia and the Pacific 1995: NDARC commissioned by the Commonwealth to design a new system to monitor drug trends in Australia to look at use and harms

A system is born Illicit Drug Reporting System (IDRS) was piloted in NSW in 1996, accruing more states each year, until becoming a national system in 2000. It consisted of three components: 1. Interviews with illicit drug users (injectors) 2. Interviews with Key Experts (law and health profession) 3. Indicator data (large population based data sets e.g. Arrests, hospital overdoses.

IDRS: Drugs of focus Heroin Cocaine Methamphetamine Speed powder Base Ice/Crystal Cannabis Other opioids

IDRS: Profile of participants 40 years old (average age) 89% heterosexual 84% were unemployed 53% single 27% completed tertiary qualifications 56% had a prison history 47% in current drug treatment Harms around injecting drug use including: vein damage, dirty hits, thrombosis, bruising, abscesses and overdose.

A sister system is born In 2000, realised there was a group of drug users and class of drugs that were not being captured by the IDRS. Namely: - these were drugs like ecstasy and LSD - more likely to be swallowed, snorted or smoked - used in social venues with music such as nightclubs Run on same premise as IDRS however instead of PWID, with regular ecstasy users

EDRS: Drugs of focus Ecstasy Cocaine Methamphetamine Speed powder Base Ice/Crystal Cannabis LSD Ketamine GHB

EDRS: Profile of participants 25 years old (average age) 16% unemployed 50% completed tertiary qualifications 5% currently in drug treatment 5% prison history Primary route of administration is not injecting Drug of choice is ecstasy Harms are related to social problems, legal problems and mental health

Aims of the projects To detect changing patterns of use and harm over time Document the price, purity, and availability of illicit drugs Point to specialised/detailed research Provide an evidence base for policy Outputs include: reports, bulletins, briefings, conference and presentations

Methodology 1 Drug user interviews 2 Key expert interviews 3 Indicator data Triangulation of sources overcomes weaknesses specific to each data source interviews Indicator data Key expert

1. Drug user interviews Face- to-face Approx. 100 in each capital city Recruited same time each year

Participant Eligibility Injected in the last 6 months Ecstasy use in the last 6 months In the market for the past year In the market for the past year Sampled from needle and syringe programs, outreach, clinics, snowballing Around 100 participants from each jurisdiction Advertised in street press, websites, music /clothing shops, universities and snowballing Around 100 participants from each jurisdiction

2. Key Expert interviews People who have regular contact with a group of illicit drug users or good knowledge of markets IDRS: NSP workers, treatment providers, outreach, law enforcement EDRS: DJs, night club industry workers, health promotion workers, first aid medical officers, youth workers, law enforcement By telephone Face-to-face 20 in each capital city

3. Indicator data Existing routine data collections with information related to illicit drugs e.g. Ambulance calls for overdoses, ED admissions, Calls to help lines, Arrest data, Drug seizure data (Customs, AFP). Heroin overdose presentations to NSW emergency departments Number of presentations 150 100 50 0 Source: Emergency Department Information System, NSW Department of Health

Analysis of routine data collections The National Illicit Drug Indicators Project (NIDIP) analyses a range of routine data collections including: 1 National Coroner s Information System 2 National Hospital Morbidity Database 3 National Drug Strategy Household Survey 4 Ambulance callouts to overdose 5 Emergency Dept presentations

Summary: So what do they tell us? What s new: drugs, harms, market characteristics What requires monitoring Areas where additional research is required 1999 2000 2004 2006 2010 2011 2012

What don t these projects tell us? Outside the city trends may exist and may not be captured May not reflect general population patterns of use regular drug users are targeted What happens if we do not monitor? We leave monitoring and priority setting to other data sources In Australia this has meant: Tabloid media & radio shock jocks. Monitoring doesn t eliminate their role, reduces their influence

Study participants Acknowledgements Agencies assisting with recruitment Agencies and individuals providing indicator data Researchers and institutions across Australia The Funders Australian Government Department of Health & Ageing

For more information Please visit the NDARC website and click on drug trends http://ndarc.med.unsw.edu.au/